Ronald DePinho, M.D.
With deep network in Houston, Boston and New York, Ronald DePinho, M.D. Ph.D (hon.) is an entrepreneur, physician and leading scientist in aging and cancer research that provides access and insight into untapped technology. Ron is a distinguished professor of the MD Anderson Cancer Center, where he served as its fourth president. He is a member of the National Academies of Science and Medicine, advisor to the Vatican, and recipient of many awards including the Ellis Island Medal of Honor. Ron is a successful biotech entrepreneur who has founded and raised capital for numerous biotech companies including publicly traded Aveo and Karyopharm. He also served as an advisor for biopharma including Abbott and GSK. Ron is Co-Founder and Vice Chair of Act for NIH and is Co-Founder and Chairman of Opa Health, a non-profit focused on disease prevention for underserved communities. He has held faculty positions at Dana-Farber, Harvard Medical School and Albert Einstein where he received his M.D. with distinction.
Ron chairs the Sporos Scientific Advisory Council in a medical and scientific capacity.
Note: Sporos and its activities are not in any way related to, or coordinated with, The University of Texas MD Anderson Cancer Center.